Identification of Stable Cell and Gene Therapeutics and Characterization of Subvisible Aggregates
In all biologics, subvisible aggregates are a critical quality attribute and key indicator of product stability. Here we present the Aura, a high-throughput, low-volume system to image, size, count, and identify subvisible aggregates and extrinsic materials across all development stages of cell and gene therapy products.
About the speaker
Dr. Karessa White is a Field Application Scientist at Halo Labs. She obtained her Ph.D. from the University of Florida in Communication Sciences and Disorders emphasizing auditory neuroscience. After spending time serving her country as a United States Army Medical Service Officer, Karessa now leverages her expertise and training in molecular biology and analytical science to help biotherapeutic developers create safe and stable drugs with Aura®.